
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Belluscura Plc | BELL | London | Ordinary Share |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
1.70 | 1.70 | 1.70 | 1.70 |
Industry Sector |
---|
HEALTH CARE EQUIPMENT & SERVICES |
Top Posts |
---|
Posted at 15/2/2025 12:00 by jaknife encarter,I'm sorry, I don't particularly follow KOD. I can't explain their actions and, looking at the chart, most long term investors would presumably be happy. I tend to steer away from the more speculative stocks that have lottery ticket style pay-offs because the lottery tickets rarely cash in! JakNife |
Posted at 15/2/2025 07:02 by encarter Take KOD for example, of which I no longer hold. It has the potential to be a massive success so one can understand why there may be some investor in the background wanting cheap stock. The vitriolic attacks have been relentless, why? |
Posted at 29/1/2025 14:09 by papillon free stock charts from uk.advfn.com5 year BELL log chart. BELL has been on a long term downhill journey for around 3 years apart from the occasional big "dead cat bounce". Definitely NOT a share for long term investors. |
Posted at 25/6/2024 06:50 by danmart2 More confetti sharesBELL was always doomed when the ‘expert’ investor buywell started pumping it |
Posted at 24/6/2024 07:04 by brummy_git Positive investor support for BelluscuraAll the details & commentary here. |
Posted at 24/6/2024 06:47 by owenski More shares issued for 300k. This business isn't performing as investors were led to believe.Avoid in my opinion. |
Posted at 13/6/2024 12:30 by hedgehog 100 eviltwin1 17 May '24 - 16:03 - 635 of 641 0 0 0"classic case of amatuerish British business failing to commercialise its innovations. Why are we so inept as a country in building companies?" 1chrism 17 May '24 - 17:06 - 636 of 641 0 3 0 "We can be thankful that they are not as inept as some of the patrons of ADVFN. Belluscura are based in the US." There is some similarity here with Polarean Imaging (POLX): which is another US lung health company that floated on AIM, but which has also disappointed greatly after an earlier large share price rise. In contrast, Newmark Security (NWT) is a British technology company that has expanded very successfully into America. From the bar graph on page 12 of NWT's annual report & accounts for the year ended 30.4.22:- "Five years of consecutive revenue growth: HCM in North America: £m" 2017: £0.9M. 2018: £1.2M. 2019: £4.0M. 2020: £5.9M. 2021: £6.5M. 2022: £8.7M. Belluscura (BELL):- Polarean Imaging (POLX):- |
Posted at 16/10/2023 13:02 by hedgehog 100 I'd also be interested in your views as to why TMTA directors Harry Hyman & Jonathan Satchell, both of whom have a billion-pound track record, are investing here, via their TMTA vehicle?For the last couple of years they will doubtless have had a good view of many potential UK tech floats, but have decided that BELL is the best opportunity available to TMTA. Their success, judgement, and business acumen should be respected. And they will have had a very good look at BELL's prospects, and its chances of delivery. The fact that Jonathan Satchell is coming on board here as a director is another major positive, and looks particularly exciting for the app and software side of BELL. It could be that J.S. is viewing BELL as a chance to replicate his success with Learning Technologies Group (LTG), which he 40-bagged from its RTO price of 5.88p/share to its high of about 236p. In addition, their 'pulling power' in attracting more institutional investors into BELL could be very positive for BELL's s.p. Those institutional investors who backed TMTA at 20p should be keen to add to their positions in BELL, and at a premium to their previous investments at 20p in TMTA (which equates to 29.33p per BELL share). |
Posted at 05/10/2023 16:18 by hedgehog 100 Thanks for posting that helpful article, Mr. Oz.From the article:- "The only risk to this 9% upside is the deal falls through and then you're stuck with a holding without a purpose." In my opinion, there's little chance of the deal falling through, because it isn't reliant upon raising any more funds. And I can't really see that BELL would fail due diligence either. Though in theory, if it did, TMTA shares would likely hold up better than BELL, because of TMTA's cash underpinning. In addition, TMTA would find another deal, possibly at an even higher premium. It looks to me that BELL are getting TMTA relatively cheaply, as the percentage premium over TMTA's cash isn't high for a RTO-type deal. I think that TMTA have probably agreed to relatively generous terms because they think that BELL is a particularly good opportunity. And going back to Stuffee's point about shell investors selling after a deal for a profit. The polar opposite can also happen, i.e. shell investors actually increasing their holdings after a takeover, if they like the new company, 'averaging up' their investment cost. The enlarged market cap. will be far higher (by multiples) than the shell, so investors can buy far more without owning too high a percentage of one company. And they will also have certainty about the business they're owning, whereas with a shell they can't be certain in advance of that. |
Posted at 04/10/2023 20:18 by hedgehog 100 Thanks Stuffee.Remember that as TMTA's IPO was at 20p (about two years ago), the vast majority of TMTA shares won't currently be showing any profit yet. The TMTA share price fell on pretty low volume, so there's been little TMTA buying below the IPO price. Also, don't underestimate the patience of shell investors - they must be some of the most patient investors out there. Because you get long periods - sometimes even years - when seemingly nothing seems to be happening. 11/10/2021 08:01 UK Regulatory (RNS & others) TMT Acquisition PLC Admission and First Day of Dealings LSE:TMTA Tmt Acquisition Plc " ... Prior to Admission, the Company had in issue 2,500,000 Ordinary Shares and at Admission issued a further 25,000,000 Ordinary Shares at a placing price of 20p per Ordinary Share, raising gross proceeds of GBP5 million. ..." |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions